Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Fields

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The American Journal of Emergency Medicine|August 19, 1999
Prehospital stability of diazepam and lorazepamM D Gottwald, L C Akers, P K Liu, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1996
New anticancer agentsG R Weiss, H A Burris 3rd, J R Eckardt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1995
Initial phase I evaluation of the novel thymidylate synthase inhibitor, LY231514, using the modified continual reassessment method for dose escalationD A Rinaldi, H A Burris, F A Dorr, et al.
American Journal of Clinical Oncology|December 1, 1994
A phase II trial of DaunoXome, liposome-encapsulated daunorubicin, in patients with metastatic adenocarcinoma of the colonJ R Eckardt, E Campbell, H A Burris, et al.
Cancer Research|December 15, 1993
A randomized phase I trial of chronic oral etoposide with or without granulocyte-macrophage colony-stimulating factor in patients with advanced malignanciesD W Shaffer, L S Smith, H A Burris, et al.
Investigational New Drugs|September 18, 1998
A phase I and pharmacokinetic trial of terephthalamidine (NSC 57155) as a 120-hour continuous infusionG I Rodriguez, J G Kuhn, G Weiss, et al.
Anti-Cancer Drugs|July 1, 1997
Phase I study with the DNA sequence-specific agent adozelesinH A Burris, V C Dieras, M Tunca, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The American Journal of Emergency Medicine|August 19, 1999
Prehospital stability of diazepam and lorazepamM D Gottwald, L C Akers, P K Liu, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1996
New anticancer agentsG R Weiss, H A Burris 3rd, J R Eckardt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1995
Initial phase I evaluation of the novel thymidylate synthase inhibitor, LY231514, using the modified continual reassessment method for dose escalationD A Rinaldi, H A Burris, F A Dorr, et al.
American Journal of Clinical Oncology|December 1, 1994
A phase II trial of DaunoXome, liposome-encapsulated daunorubicin, in patients with metastatic adenocarcinoma of the colonJ R Eckardt, E Campbell, H A Burris, et al.
Cancer Research|December 15, 1993
A randomized phase I trial of chronic oral etoposide with or without granulocyte-macrophage colony-stimulating factor in patients with advanced malignanciesD W Shaffer, L S Smith, H A Burris, et al.
Investigational New Drugs|September 18, 1998
A phase I and pharmacokinetic trial of terephthalamidine (NSC 57155) as a 120-hour continuous infusionG I Rodriguez, J G Kuhn, G Weiss, et al.
Anti-Cancer Drugs|July 1, 1997
Phase I study with the DNA sequence-specific agent adozelesinH A Burris, V C Dieras, M Tunca, et al.
Pageof 2